Tracking tau fibrillogenesis and consequent primary phagocytosis of neurons mediated by microglia in a living tauopathy model
Takuwa, H.; Orihara, A.; Takado, Y.; Shimojo, M.; Ishikawa, A.; Takahash, M.; Barron, A. M.; Ono, M.; Maeda, J.; Masamoto, K.; Akatsu, H.; Tolkovsky, A. M.; Ji, B.; Tomita, Y.; Ito, H.; Zhang, M.-R.; Goedert, M.; Spillantini, M. G.; Lee, V. M.-Y.; Trojanowski, J. Q.; Maehara, T.; Suhara, T.; Sahara, N.; Higuchi, M.
Show abstract
Fibrillary tau pathologies have been implicated in Alzheimers and allied neurodegenerative diseases, while mechanisms by which neurons bearing tau tangles die remain enigmatic. To address this issue, we pursued tau and related key pathologies macroscopically by PET and MRI and microscopically by intravital two-photon laser optics. Time-course macroscopic assays of tau transgenic mice demonstrated intimate associations of tau deposition and increase of an inflammatory microglial marker, translocator protein (TSPO), with regional brain atrophy. Longitudinal microscopy of these mice revealed a rapid turnover of tau lesions resulting from continuous generation of new tau aggregates followed by loss of neurons and their fibrillar contents. This technology also allowed the capturing of the disappearance of tangle-bearing neurons several days after being engulfed by activated microglia. Notably, a therapeutic TSPO ligand profoundly suppressed the mobility and phagocytotic activity of microglia and improved neuronal survival in this model, supporting the involvement of primary phagocytosis of viable neurons by microglia in tau-primed neuronal death. Finally, partial depletion of microglia revealed roles of immune factors, MFG-E8 and C1q, as eat-me signals for an immediate attraction of phagocytic microglia towards the elimination of tangle-loaded neurons.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau 96%
- Genome-wide association study and functional validation implicates JADE1 in tauopathy 96%
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003 96%
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 96%
- DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity 95%
Similar papers in this journal
- Proteostasis as a fundamental principle of Tau immunotherapy 96%
- Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome 94%
- Peripheral inflammatory markers relate to central inflammation and survival in syndromes associated with frontotemporal lobar degeneration 94%
Similar papers in this journal
- Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy 97%
- Plasma p-tau212: antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology 96%
- Opposing roles of physiological and pathological amyloid-β on synapses in live human brain slice cultures 96%
Similar papers in this journal
- A peptide inhibitor of Tau-SH3 interactions ameliorates amyloid-β toxicity 95%
- Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer's disease 95%
- Extracellular tau clearance is governed by its aggregation state and independent of microglial activation by LPS and IFN-γ 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.